TD Asset Management Inc

Position in PHVS — Pharvaris N.V.

CIK 1056053 Toronto, A6

Position in PHVS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,329,877

-$218,957 QoQ

Shares Held

38,458

-29.9% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 124 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. PHVS ranks #88 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,329,877	38,458	-29.9%	Shares	Sole	2026-08-04
2026-03-31	$1,548,834	54,826	-54.4%	Shares	Sole	2026-05-11
2025-12-31	$3,336,882	120,248	+15.2%	Shares	Sole	2026-02-10
2025-09-30	$2,603,682	104,356	+4.9%	Shares	Sole	2025-11-10
2025-06-30	$1,751,376	99,510	+27.4%	Shares	Sole	2025-07-28
2025-03-31	$1,226,515	78,122	+41.5%	Shares	Sole	2025-05-07
2024-12-31	$1,058,490	55,216	+52.5%	Shares	Sole	2025-02-11
2024-09-30	$670,720	36,216	-57.8%	Shares	Sole	2024-11-01
2024-06-30	$1,613,340	85,816	-23.8%	Shares	Sole	2024-08-02
2024-03-31	$2,602,555	112,616	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.